viewThe Valens Company

The Valens Company strikes two new multi-year supply and extraction deals

It signed deals with cannabis cultivator Emerald Health Therapeutics and edibles producer Dynaleo

cbd oils
Valens will be processing biomass into resins and supplying emulsions for use in edibles

Valens GroWorks Corp (CVE:VLNS) (OTCMKTS:VLNCF) announced two major multi-year extraction and supply deals on Monday, its first moves since rebranding to The Valens Company

The first deal with cannabis producer Emerald Health Therapeutics Inc (CVE:EMH) will see Valens process cannabis and hemp biomass into resins and distillates. 

Under a separate agreement, Valens will supply edibles producer Dynaleo with distillate to use in the production of CBD ingestible products.

READ: Valens GroWorks rebrands to The Valens Company

In the Emerald deal, Valens signed a four-year deal that sees the extraction company processing a minimum of 10,000 kilograms per year of cannabis and hemp biomass, supplied by Emerald.

Valens will process the biomass into resins and distillates on a fee-for-service basis.

In addition, Valens will supply Emerald with white label services such as formulation, mixing and filing for products like vaporizers, softgels and tinctures.

The deal is expected to kick off in the first quarter of 2020.

"We are excited to partner with Emerald Health to provide our extraction and white label expertise to bolster their product platform," said Tyler Robson, CEO of The Valens Company, calling Emerald Health “one of the industry's leading players.”

Emerald Health’s CEO Riaz Bandali said the company was excited to have Valens onboard as a strategic partner. "Beyond being an industry leader in extraction, formulation, and other services, Valens' cost-effective end-to-end fulfillment solution can help transition our novel product ideas into tangible products in a faster and more cost-effective manner,” Bandali said in a statement.

Dynaleo deal

The deal with Dynaleo, meanwhile, sees Valens supplying the edibles producer with distillate or SōRSE emulsions containing a minimum of 40 kilograms of active THC or CBD cannabinoids, the company told investors.

The agreement has an initial two-year term with two automatic one-year renewals. During the third year of the deal, Dynaleo will purchase at least 50 kilograms in distillate or SōRSE emulsions and 75 kilograms in the fourth year.

According to the terms, if Dynaleo decides to receive emulsified, high-potency cannabis oil, it will be processed using Valens’ SōRSE technology for an additional charge.

READ: Valens widens exclusive licence pact to bring cannabis-infusion technology to new markets

Valens president Jeff Fallows said the company was excited to be working with Dynaleo on its edibles production.

"The team at Dynaleo have been active in the Canadian cannabis sector for many years advocating for safe, high-quality edibles for the adult use market,” Fallows said in a statement. Fallows said that Valens will be supporting Dynaleo’s operations with quality active cannabis inputs as Dynaleo builds a state-of-the-art, large scale facility due to come online in 2020.

The new facility gives Dynaleo the capacity to produce more than 400 million units in its first year of operations, according to Fallows.

Valens also said it had received regulatory approval to change its OTCQX ticker symbol to “VLNCF.”

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Quick facts: The Valens Company

Price: 1.62 CAD

Market: TSX
Market Cap: $207.92 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of The Valens Company named herein, including the promotion by the Company of The Valens Company in any Content on the Site, the Company receives...


The Valens Company remains very busy with new products and global expansion...

The Valens Company (TSE: VLNS-OTCQX: VLNCF) President Jeff Fallows joined Steve Darling from Proactive to discuss an extremely busy 3rd quarter for the company that saw them push out a record 56 SKU’s. Fallows talked about that and he also answers the question, "What is the biggest...

4 weeks, 1 day ago

3 min read